Singapore markets closed

Sedana Medical AB (publ) (7D2A.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.9020+0.1020 (+5.67%)
As of 08:07AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 193.37M
Enterprise value 162.44M
Trailing P/E N/A
Forward P/E 1.11k
PEG ratio (5-yr expected) N/A
Price/sales (ttm)12.31
Price/book (mrq)2.05
Enterprise value/revenue 10.79
Enterprise value/EBITDA -2.65

Trading information

Stock price history

Beta (5Y monthly) 0.16
52-week change 3-25.67%
S&P500 52-week change 326.94%
52-week high 32.9000
52-week low 31.1620
50-day moving average 31.5169
200-day moving average 31.6316

Share statistics

Avg vol (3-month) 328
Avg vol (10-day) 3169
Shares outstanding 599.34M
Implied shares outstanding 6107.43M
Float 867.44M
% held by insiders 125.08%
% held by institutions 150.81%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 24:1
Last split date 326 May 2021

Financial highlights

Currency in SEK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -13.85%
Operating margin (ttm)-18.08%

Management effectiveness

Return on assets (ttm)-3.47%
Return on equity (ttm)-2.28%

Income statement

Revenue (ttm)164.91M
Revenue per share (ttm)1.66
Quarterly revenue growth (yoy)29.20%
Gross profit (ttm)N/A
EBITDA -56.28M
Net income avi to common (ttm)-22.83M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)360.91M
Total cash per share (mrq)3.63
Total debt (mrq)4.28M
Total debt/equity (mrq)0.43%
Current ratio (mrq)8.11
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-22.71M
Levered free cash flow (ttm)-206.37M